All Curated Mutation Sites in HTLV1 
Back to Mutation Home

 The Virus Mutation(VM) module provides researchers the annotations of reported pathogenic mutations in HTLV1 related to human diseases. The curated VM information includes mutation site, mutation level, virus gene/protein/region, virus-associated disease, genotype/subtype, literature evidence, etc.


Browse Data by Virus Gene/Protein/Region, Disease OR Description
*Please select one option you are interested in, the page will be automatically redirected.
     
     

Click the button below to quickly view the viral genes/regions/protein for mutation

Show All
  
env
  
tax
  
gag
  
gp46
  
HBZ
  
LTR
  
TRE
  
ORF-I
  
p12
  
p30
  
rex
  
pX
  

Keyword: TRE
ID PMID Mutation Gene/Protein/Region Encoding Gene/Protein Disease Description Detail
1 34494950 A125G
TRE
Paraparesis, Tropical Spastic
G
R
S
C
 View
2 34494950 G174A
TRE
Paraparesis, Tropical Spastic
G
R
S
C
 View
3 22947305 G232A
TRE
HTLV-1-HIV Coinfection
R
S
C
L
 View
4 22947305 A184G
TRE
HTLV-1-HIV Coinfection
R
S
C
L
 View
5 26516904 8428_8429 ins A
LTR;TRE
HTLV-1 Infection
Carrier State
S
C
L
 View
6 26516904 G8446A
LTR;TRE
HTLV-1 Infection
Carrier State
S
C
L
 View
7 26516904 G8471T
LTR;TRE
HTLV-1 Infection
Carrier State
S
C
L
 View
8 26516904 C8420T
LTR;TRE
HTLV-1 Infection
Carrier State
S
C
L
 View
9 26516904 8509_8511 del A
LTR;TRE
HTLV-1 Infection
Carrier State
S
C
L
 View
10 26516904 A8509G
LTR;TRE
HTLV-1 Infection
Carrier State
S
C
L
 View
11 26516904 G8545A
LTR;TRE
HTLV-1 Infection
Carrier State
S
C
L
 View
12 26516904 T8522C
LTR;TRE
HTLV-1 Infection
Carrier State
S
C
L
 View
13 26516904 T8546C
LTR;TRE
HTLV-1 Infection
Carrier State
S
C
L
 View
14 26516904 A8403G
LTR;TRE
HTLV-1 Infection
Carrier State
S
C
L
 View
15 22166003 G232A
TRE
HTLV-1 Infection
C
 View
16 22166003 A184G
TRE
HTLV-1 Infection
C
 View
Contents
Description

The table shows all curated mutation sites of HTLV1 in each literature

Table Description Column Note
D
The study mentioned a certain treatment method, such as drug resistance caused by mutations.
G
The study mentioned the virus genotype/subtype information.
R
The study mentioned the reference sequence used for comparison, or the original strain of the virus used for site-directed mutagenesis.
S
The study provided sequence information or accession numbers.
L
The study provided the geographic region/country of data origin.
C
The study provided clinical baseline information.
I
The study involved information related to immune.
T
The study involved host target genes.